Tetramethyluric acid


CAS No. : 2309-49-1

(Synonyms: 1,3,7,9-Tetramethyluric acid; Theacrine)

2309-49-1
Price and Availability of CAS No. : 2309-49-1
Size Price Stock
5g $13 In-stock
25g $32 In-stock
100g $121 In-stock
200 g Get quote
500 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-119575
M.Wt: 224.22
Formula: C9H12N4O3
Purity: >98 %
Solubility: DMSO : 5 mg/mL (ultrasonic;warming;heat to 60°C);H2O : 25 mg/mL (ultrasonic)
Introduction of 2309-49-1 :

Tetramethyluric acid (1,3,7,9-Tetramethyluric acid) is an orally active purine alkaloid in Coffea species and Camellia kucha. Tetramethyluric acid exhibits antiviral, and anti-inflammatory activity. Tetramethyluric acid can be used for the research of inflammation disease, and influenza virus infection[1][2][3][4][5]. In Vitro:Tetramethyluric acid (50-100 μM) exhibits anti-influenza virus activity in MDCK cells, inhibiting NS1 protein expression[1].
Tetramethyluric acid (1.5×10-2 M) reduces 32P-labelled orthophosphate incorporation into DNA and RNA and increases ATP levels by 40% in excised Vicia faba root tips[2].
Tetramethyluric acid (2×10-2 M; 120 min) induces chromosomal aberrations in Vicia faba root tips[2]. In Vivo:Tetramethyluric acid (10 mg/kg; p.o.) upregulates collagen II, SIRT3, FOXO3a, and SOD2 expression to improve intervertebral disc degeneration in mice[1].
Tetramethyluric acid (20 mg/kg; i.g.) improves cardiac function in ovariectomized mice with myocardial infarction by activating SIRT3 and reducing myocardial fibrosis and apoptosis[1].
Tetramethyluric acid (8-32 mg/kg; p.o.; single dose) significantly inhibits Xylene-induced ear edema and λ-Carrageenan (HY-N9470)-induced hind paw edema[1].
Tetramethyluric acid (10-30 mg/kg; p.o.; daily; 7 days) reduces hepatic inflammation and liver damage in restraint-stressed mice[1].
Tetramethyluric acid (12.5-25.0 mg/kg; p.o.) attenuates FIA-induced rheumatoid arthritis in SD rats via the TGF-β/SMAD pathway[1].
Tetramethyluric acid (24-48 mg/kg; i.p.; single pre-treatment dose) significantly attenuates adenosine receptor agonist-induced motor depression in Long Evans rats via adenosergic and dopaminergic systems[1].
Tetramethyluric acid (5-15 mg/kg; p.o.) reverses restraint stress-induced learning and memory impairment in male Kunming mice[1].
Tetramethyluric acid (3-30 mg/kg; i.g.) produces antidepressant effects in male NIH mice by modulating monoamine neurotransmitters[1].
Tetramethyluric acid (10-20 mg/kg; p.o.) ameliorates HFD-induced NAFLD in C57BL/6 mice via the SIRT3/LCAD signaling pathway[1].

Your information is safe with us.